New Objective Announces Upcoming Webinar: Robert Salzler of Regeneron Pharmaceuticals

February 7, 2023 – Littleton, MA (USA) New Objective, Inc., the market leader in innovative solutions for nanoflow and microflow LC-MS, announces its upcoming webinar featuring the PicoChip and its integration as a standardized platform for immunopeptidomics. Mike Lee, CEO together with Emily Ehrenfeld, President of New Objective will be welcoming Robert Salzler, Regeneron Pharmaceuticals, to share recent experiences and ongoing work using the PicoChip, a standardized platform in use for proteomic analysis at Regeneron and his talk titled Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues.  

The event, scheduled for Wednesday February 15th, 2023 will feature a format similar to the engaging discussions established by CPSA Everyday, sharing a common focus to standardize, unify and industrialize as told through the framework of technology, solutions and regulations, for the patient. As outlined in the agenda, the discussions will be led by thought leaders across industry who will share insights on developing standardized methods and workflows with a focus on the patient with human samples.

• Welcome
  • Mike Lee – New Objective
• Opening Remarks
  • Emily Ehrenfeld – New Objective
  • Amanda Berg – New Objective
• Introduction
  • Helena Svobodova – New Objective
• Featured Speakers
  • Robert Salzler and Mayank Srivastava – Regeneron
• Discussion
• Closing Remarks
  • Amanda Berg – New Objective
  • Emily Ehrenfeld – New Objective
• Adjourn
  • Mike Lee – New Objective

Wednesday’s event will be an exclusive event and will build on ongoing discussions as shared through New Objective Everyday events and CPSA Everyday and CPSA Annual meetings.